Research Papers:
Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2689 views | HTML 3120 views | ?
Abstract
Ana González-Sánchez1, Myriam Jaraíz-Rodríguez1, Marta Domínguez-Prieto1, Sandra Herrero-González1, José M. Medina1, Arantxa Tabernero1
1Instituto de Neurociencias de Castilla y León (INCYL), Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Salamanca, Spain
Correspondence to:
Arantxa Tabernero, email: [email protected]
Keywords: connexin, Src, glia, CNS, gap junctions
Received: December 10, 2015 Accepted: June 26, 2016 Published: July 06, 2016
ABSTRACT
Connexin43 (Cx43), the major protein forming gap junctions in astrocytes, is reduced in high-grade gliomas, where its ectopic expression exerts important effects, including the inhibition of the proto-oncogene tyrosine-protein kinase Src (c-Src). In this work we aimed to investigate the mechanism responsible for this effect. The inhibition of c-Src requires phosphorylation at tyrosine 527 mediated by C-terminal Src kinase (Csk) and dephosphorylation at tyrosine 416 mediated by phosphatases, such as phosphatase and tensin homolog (PTEN). Our results showed that the antiproliferative effect of Cx43 is reduced when Csk and PTEN are silenced in glioma cells, suggesting the involvement of both enzymes. Confocal microscopy and immunoprecipitation assays confirmed that Cx43, in addition to c-Src, binds to PTEN and Csk in glioma cells transfected with Cx43 and in astrocytes. Pull-down assays showed that region 266–283 in Cx43 is sufficient to recruit c-Src, PTEN and Csk and to inhibit the oncogenic activity of c-Src. As a result of c-Src inhibition, PTEN was increased with subsequent inactivation of Akt and reduction of proliferation of human glioblastoma stem cells. We conclude that the recruitment of Csk and PTEN to the region between residues 266 and 283 within the C-terminus of Cx43 leads to c-Src inhibition.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10454